User menu

Early relapse with tumefactive MS lesion upon initiation of fingolimod therapy.

Bibliographic reference Boangher, Sabina ; Goffette, Sophie ; Van Pesch, Vincent ; Mespouille, Pascal. Early relapse with tumefactive MS lesion upon initiation of fingolimod therapy.. In: Acta Neurologica Belgica, Vol. 116, no.1, p. 95-97 (2015)
Permanent URL http://hdl.handle.net/2078.1/172009
  1. Visser F., Wattjes M. P., Pouwels P. J. W., Linssen W. H. J. P., van Oosten B. W., Tumefactive multiple sclerosis lesions under fingolimod treatment, 10.1212/wnl.0b013e3182735cb3
  2. Pilz G., Harrer A., Wipfler P., Oppermann K., Sellner J., Fazekas F., Trinka E., Kraus J., Tumefactive MS lesions under fingolimod: A case report and literature review, 10.1212/01.wnl.0000435293.34351.11
  3. Hellmann M.A., Lev N., Lotan I., Mosberg-Galili R., Inbar E., Luckman J., Fichman-Horn S., Yakimov M., Steiner I., Tumefactive demyelination and a malignant course in an MS patient during and following fingolimod therapy, 10.1016/j.jns.2014.06.013
  4. Totaro R, Carmine CD, Carolei A (2014) Tumefactive demyelinating lesions in patients with relapsing remitting multiple sclerosis treated with Fingolimod. J Neurol Neurophysiol S12:006. doi: 10.4172/2155-9562.S12-006
  5. Fleming J, West M (2014) Reversible Cerebral Vasoconstriction Syndrome and Fingolimod: Culprit or Innocent Bystander (P2.224). Neurology 82(10 Supplement):P2.224